Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Pharmaids Pharmaceuticals Ltd Performance

Today's Low
52.27
arrowIcon
Today's High
52.27
52 Wk Low
27.77
arrowIcon
52 Wk High
79.23


Open

52.27

Traded Value (Cr)

1.93 L

Prev. Close

53.33

VWAP

52.27

Volume

3,691

Face Value

10

Pharmaids Pharmaceuticals Ltd Fundamentals

Market Cap
₹ 119 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
5.42
Debt to Equity
0.00
ROE
-42.06 %
EPS (TTM)
0.00
Dividend Yield
0.00%
Book Value
9.84

Click here to know more about Fundamentals

Pharmaids Pharmaceuticals Ltd Financials

Pharmaids Pharmaceuticals Ltd Financials

Pharmaids Pharmaceuticals Ltd Shareholding Pattern

Held By Apr 2024 Mar 2024 Dec 2023 Sep 2023
Others 53.30 % 53.30 % 29.96 % 8.37 %
Retail 41.06 % 41.06 % 60.78 % 81.93 %
Promoters 5.64 % 5.64 % 9.25 % 9.70 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Others

53.30%

Retail

41.06%

Promoters

5.64%

FII

0.00%

Mutual Funds

0.00%

Others

53.30%

Retail

41.06%

Promoters

5.64%

FII

0.00%

Mutual Funds

0.00%

Others

29.96%

Retail

60.78%

Promoters

9.25%

FII

0.00%

Mutual Funds

0.00%

Others

8.37%

Retail

81.93%

Promoters

9.70%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹53.34

PIVOT

resistance-arrow
Resistance
First Resistance₹53.343
Second Resistance₹53.357
Third Resistance₹53.363
support-arrow
Support
First Resistance₹53.323
Second Resistance₹53.317
Third Resistance₹53.303
RSI7.405
MACD-1.769
ADX21.881
CCI-101.094

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day5,2255,225100.00
Week4,1004,100100.00
1 Month11,30411,304100.00
6 Months000.00

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd is a public limited company incorporated on 01st March 1989. The Company is primarily engaged in business of manufacturing of bulk drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. In FY19, the proposed Scheme of Amalgamation of M/s. Emergent Bio Naturals Ltd (Transferor Company) into M/s. Pharmaids Pharmaceuticals Ltd (Transferee Company) pursuant to section 230 to 232 of the Companies Act, 2013 is pending for approval before the NCLT, Hyderabad Bench.

Managing Director

Founded

1989

NSE Symbol

Pharmaids Pharmaceuticals Ltd Management

NameDesignation
Venu Madhava KaparthyE D & Wholetime Director
Mini ManikantanE D & Wholetime Director
Sadhanala Venkata RaoNon-Exec & Non-Independent Dir
P N VijayIndependent Non Exe. Director
M Sudheer AnandIndependent Non Exe. Director
Methuku NageshIndependent Non Exe. Director
Shreedhara ShettyAdditional Director
Sadhanala Venkata RaoNon Executive Director
Shankarappa Nagaraja Vinaya BabuChairman & Director

Pharmaids Pharmaceuticals Ltd News

Pharmaids Pharmaceuticals reports standalone net loss of Rs 1.63 crore in the December 2023 quarter
Sales reported at Rs 0.02 crore
Pharmaids Pharmaceuticals to convene board meeting
On 12 February 2024
Pharmaids Pharmaceuticals EGM scheduled
On 31 January 2024
Pharmaids Pharmaceuticals to conduct board meeting
On 6 January 2024
Pharmaids Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the September 2023 quarter
Reported sales nil
Pharmaids Pharmaceuticals to announce Quarterly Result
On 11 November 2023
Pharmaids Pharmaceuticals AGM scheduled
On 22 September 2023
Pharmaids Pharmaceuticals to conduct board meeting
On 29 August 2023
Pharmaids Pharmaceuticals reports standalone net loss of Rs 1.30 crore in the June 2023 quarter
Reported sales nil
Pharmaids Pharmaceuticals schedules board meeting
On 4 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,61,399 Cr
₹ 1,506.25
(0.86 %)
87.73
CIPLA₹ 1,08,146 Cr
₹ 1,339.45
(-1.42 %)
29.12
DIVISLAB₹ 1,00,599 Cr
₹ 3,791.95
(0.06 %)
73.75
DRREDDY₹ 98,703 Cr
₹ 5,916.80
(0.64 %)
22.73
ZYDUSLIFE₹ 97,383 Cr
₹ 983.05
(1.58 %)
36.23

Pharmaids Pharmaceuticals Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Pharmaids Pharmaceuticals Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Pharmaids Pharmaceuticals Ltd's share price is ₹52.27 as of May 10, 2024

Pharmaids Pharmaceuticals Ltd's P/E ratio is 0.00 times as of May 10, 2024.

Pharmaids Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 5.42, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Pharmaids Pharmaceuticals Ltd's market is 120 Cr as on May 10, 2024.

The current financial records of Pharmaids Pharmaceuticals Ltd show a -42.06% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Pharmaids Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Pharmaids Pharmaceuticals Ltd's 52-week high and low as of May 10, 2024 are ₹52.27 and ₹52.27 respectively.

As of the Apr 2024 quarter, the promoter shareholding in Pharmaids Pharmaceuticals Ltd stands at 5.64%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.